Your search returned the following 18 documents:

18. Accurate prediction of drug-exposure without using established drug-resistance mutations
    Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    In: Antiviral Therapy, Berlin, Germany, 2014, A75 p.
    
17. Accurate prediction of drug-exposure without using established drug-resistance mutations
    Alejandro Pironti, Nico Pfeifer, and Thomas Lengauer
    In: Antiviral Therapy, Berlin, Germany, 2014, A75 p.
    
16. Improved HIV-1 drug-exposure reconstruction with linear support vector machines
    Alejandro Pironti, Nico Pfeifer, and Thomas Lengauer
    In: Reviews in Antiviral Therapy & Infectious Diseases, Barcelona, Spain, 2014, 67 p.
    
15. Improved HIV-1 drug-exposure reconstruction with linear support vector machines
    Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    In: Reviews in Antiviral Therapy & Infectious Diseases, Barcelona, Spain, 2014, 67 p.
    
14. Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences
    Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    In: Abstract Supplement of the HIV Drug Therapy Glasgow Congress 2014, Glasgow, UK, 2014, 155 p.
    
13. Simulation of Sanger-sequencing errors in the context of genotypic tropism determination
    Alejandro Pironti, Saleta Sierra, Rolf Kaiser, Thomas Lengauer, and Nico Pfeifer
    In: Antiviral Therapy, Berlin, Germany, 2014, A81 p.
    
12. Simulation of Sanger-sequencing errors in the context of genotypic tropism determination
    Alejandro Pironti, Thomas Lengauer, and Nico Pfeifer
    In: Antiviral Therapy, Berlin, Germany, 2014, A81 p.
    
11. Effects of sequencing errors on geno2pheno[coreceptor] predictions
    Alejandro Pironti, Thomas Lengauer, and Nico Pfeifer
    In: Abstract Book 11th European Meeting on HIV & Hepatitis, Rome, Italy, 2013, 23-24
    
10. HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure
    Alejandro Pironti
    Infection, Genetics and Evolution 19: 349–360 p., 2013
    
9. In silico analysis of the effects of sequencing errors on geno2pheno[coreceptor]
   Alejandro Pironti, Thomas Lengauer, and Nico Pfeifer
   In: Abstract Book of the International Workshop on HIV&Hepatitis Virus, Toronto, Canada, 2013, A142 p.
   
8. Characterization of HIV-1 Gag Subtype C
   Alejandro Pironti, Thomas Lengauer, Rolf Kaiser, Eugen Schülter, and Jens Verheyen
   In: Abstract Book. 9th Workshop on HIV \& Hepatitis Treatment Strategies \& Antiviral Drug Resistance, Barcelona, Spain, 2012, 40-41
   
7. Etravirine in protease inhibitor-free antiretroviral combination therapies
   Eugen Schuelter, Nadine Lübcke, Björn Jensen, Maurizio Zazzi, Anders Sönnerborg, Thomas Lengauer, Francesca Incardona, Richardo Camacho, J Schmit, Bonaventura Clotet, Rolf Kaiser, and Alejandro Pironti
   In: Journal of the International AIDS Society, Glasgow, UK, 2012, 155-156
   
6. HIV-GRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge
   Martin Obermeier, Alejandro Pironti, Thomas Berg, Patrick Braun, Martin Däumer, Josef Eberle, Robert Ehret, Rolf Kaiser, Niels Kleinkauf, Klaus Korn, Claudia Kücherer, Harm Müller, Christian Noah, Martin Stürmer, Alexander Thielen, Eva Wolf, and Hauke Walter
   Intervirology 55: 102-107, 2012
   
5. HIV2EU: supporting standardized HIV-2 drug resistance interpretation in Europe
   Martin Obermeier, Ricardo Camacho, Charlotte Charpentier, Diane Deschamps, Joseph Eberle, Lutz Gürtler, Jean Ruelle, Alejandro Pironti, Francoise Brun-Veziet, Martin Stürmer, and Rolf Kaiser
   In: Journal of the International AIDS Society, Glasgow, UK, 2012, 135 p.
   
4. Optimisation of baseline genotypic testing for safe and efficient maraviroc administration
   Saleta Sierra, Jan Nikolaj Dzbowski, Alejandro Pironti, L Gueney, Alexander Thielen, Stefan Reuter, Stefan Esser, Gerd Fätkenheuer, Thomas Lengauer, Dominik Hider, Daniel Hoffmann, Holger Pfister, Björn Jensen, and Rolf Kaiser
   In: Journal of the International AIDS Society, Glasgow, UK, 2012, 101-102
   
3. A Computational Method for Predicting First-Line Antiretroviral Therapy Success
   Alejandro Pironti, André Altmann, Joachim Büch, and Thomas Lengauer
   In: Abstract Book. 9th Workshop on HIV & Hepatitis Treatment Strategies & Antiviral Drug Resistance, Paphos, Cyprus, 2011, 94 p.
   
2. Probabilistic disease gene prioritization
   Alejandro Pironti
   Master's thesis, Universität des Saarlandes, 2009
   
1. Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data
   Andre Altmann, Alejandro Pironti, Juliane Perner, Joachim Büch, and Thomas Lengauer
   In: Abstract Book. 8th European Drug Resistance Workshop, Sorrento, Italy, 2010, 46 p.